Real-time enrollment status for this acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:13 AM UTC
| NCT Number | NCT04521231 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 281 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | April 16, 2026 (Yesterday) |
As of April 17, 2026: Clinical trial NCT04521231 is currently recruiting participants. This clinical trial study for acute lymphoblastic leukemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04521231 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04521231 was last updated Yesterday (April 16, 2026). HelloStudys verifies this status automatically.